Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Syncom Formulations (India)
₹17.39
+0.02 (0.12%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
17.34Prev. Close
17.37Volume
4,53,370Total traded value
0.79 CrUpper Circuit
18.23Lower Circuit
16.50Fundamentals
| Market Cap | ₹1,633Cr |
| ROE | 14.45% |
| P/E Ratio(TTM) | 28.48 |
| EPS(TTM) | 0.61 |
| P/B Ratio | 4.77 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.33 |
| Book Value | 3.64 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Syncom Formulations (india)
Syncom Formulations manufactures and sells over 200 pharmaceutical products, including tablets, capsules, liquids, and various types of injections. The company operates on the principle of a 'synergistic combination of commitment and consistency' to maintain its reputation in the industry. As a leading vaccine manufacturer, it contributes to India's global market share of about 60%.;
| Parent Organisation | Syncom Formulations (india) |
| Managing Director | Shri. Vijay Bankda |
| NSE Symbol | SYNCOMF |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.75 | ||
| Gland Pharma | NA (0.00%) | 43.16 | ||
| Ajanta Pharma | NA (0.00%) | 34.16 | ||
| Eris Lifesciences | NA (0.00%) | 57.46 |